Madopar CR capsules イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar cr capsules

roche products ltd - benserazide hydrochloride; levodopa - modified-release capsule - 25mg ; 100mg

Madopar 50mg/12.5mg capsules イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 50mg/12.5mg capsules

roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 12.5mg ; 50mg

Madopar 200mg/50mg capsules イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 200mg/50mg capsules

roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 50mg ; 200mg

Madopar 50mg/12.5mg dispersible tablets イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 50mg/12.5mg dispersible tablets

roche products ltd - benserazide hydrochloride; levodopa - dispersible tablet - 12.5mg ; 50mg

Madopar 100mg/25mg dispersible tablets イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 100mg/25mg dispersible tablets

roche products ltd - benserazide hydrochloride; levodopa - dispersible tablet - 25mg ; 100mg

MADOPAR 100/25 Milligram Tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

madopar 100/25 milligram tablets

roche products limited - levodopa, benserazide hydrochloride - tablets - 100/25 milligram - dopa and dopa derivatives

MADOPAR 200/50 Milligram Capsules Hard アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

madopar 200/50 milligram capsules hard

roche products limited - levodopa, benserazide hydrochloride - capsules hard - 200/50 milligram - dopa and dopa derivatives

MADOPAR 50/12.5 Milligram Tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

madopar 50/12.5 milligram tablets

roche products limited - levodopa, benserazide hydrochloride - tablets - 50/12.5 milligram - dopa and dopa derivatives

Madopar 100mg/25mg capsules イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 100mg/25mg capsules

roche products ltd - levodopa; benserazide hydrochloride - oral capsule - 100mg ; 25mg

Madopar ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

madopar

roche products (nz) ltd - benserazide hydrochloride 57mg equivalent to to 50 mg benserazide base; levodopa 200mg;   - capsule - 250 mg - active: benserazide hydrochloride 57mg equivalent to to 50 mg benserazide base levodopa 200mg   excipient: gelatin indigo carmine iron oxide red iron oxide yellow magnesium stearate microcrystalline cellulose povidone purified talc titanium dioxide - madopar is indicated for the treatment of all forms of parkinson's syndrome with the exception of medicine-induced parkinsonism.